Evidence map›Paper›PMID 25045278›Full record

ReviewInternational journal of nephrology and renovascular disease2014

Vascular access for hemodialysis: current perspectives.

Domenico Santoro, Filippo Benedetto, Placido Mondello, Narayana Pipitò, David Barillà, Francesco Spinelli, Carlo Alberto Ricciardi, Valeria Cernaro, Michele Buemi

2 registry-linked trialsAbstract readReview
In one paragraph

Review in International journal of nephrology and renovascular disease, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 124 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
124citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06411353 narecruitingnot on this mapstarted 2025, after this paper: background citation

The Relationship Between Blood Flow Conditions and Sounds in Arteriovenous Fistulae for Hemodialysis

TypeinterventionalSponsorMario Negri Institute for Pharmacological ResearchRan2025 to 2028Enrolled15ConditionsEnd Stage Renal DiseaseArmsMRI acquisition, US examination
NCT06855914 nanot yet recruitingnot on this mapstarted 2025, after this paper: background citation

Outcomes of Surgical Management of Aneurysmal Arteriovenous Fistula in Hemodialysis Patients

TypeinterventionalSponsorAssiut UniversityRan2025 to 2026Enrolled46ConditionsArteriovenous Fistula PatencyArmssurgerical repair
3 · Its place in the literature

Who cites it

124 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Medical Adjuvant Therapy in Reducing Thrombosis With Arteriovenous Grafts and Fistulae Use: A Meta-Analysis of Randomized Controlled Trials.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

64 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Domenico SantoroDepartment of Clinical and Experimental Medicine, Unit of Nephrology, University of Messina, Italy.
Filippo BenedettoUnit of Vascular Surgery, University of Messina, Italy.
Placido MondelloUnit of Infectious Disease, University of Messina, Italy.
Narayana PipitòUnit of Vascular Surgery, University of Messina, Italy.
David BarillàUnit of Vascular Surgery, University of Messina, Italy.
Francesco SpinelliUnit of Vascular Surgery, University of Messina, Italy.
Carlo Alberto RicciardiDepartment of Clinical and Experimental Medicine, Unit of Nephrology, University of Messina, Italy.
Valeria CernaroDepartment of Clinical and Experimental Medicine, Unit of Nephrology, University of Messina, Italy.
Michele BuemiDepartment of Clinical and Experimental Medicine, Unit of Nephrology, University of Messina, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A well-functioning vascular access (VA) is a mainstay to perform an efficient hemodialysis (HD) procedure. There are three main types of access: native arteriovenous fistula (AVF), arteriovenous graft, and central venous catheter (CVC). AVF, described by Brescia and Cimino, remains the first choice for chronic HD. It is the best access for longevity and has the lowest association with morbidity and mortality, and for this reason AVF use is strongly recommended by guidelines from different countries. Once autogenous options have been exhausted, prosthetic fistulae become the second option of maintenance HD access alternatives. CVCs have become an important adjunct in maintaining patients on HD. The preferable locations for insertion are the internal jugular and femoral veins. The subclavian vein is considered the third choice because of the high risk of thrombosis. Complications associated with CVC insertion range from 5% to 19%. Since an increasing number of patients have implanted pacemakers and defibrillators, usually inserted via the subclavian vein and superior vena cava into the right heart, a careful assessment of risk and benefits should be taken. Infection is responsible for the removal of about 30%-60% of HD CVCs, and hospitalization rates are higher among patients with CVCs than among AVF ones. Proper VA maintenance requires integration of different professionals to create a VA team. This team should include a nephrologist, radiologist, vascular surgeon, infectious disease consultant, and members of the dialysis staff. They should provide their experience in order to give the best options to uremic patients and the best care for their VA.

Indexed as

arteriovenous fistulacentral venous catheterinfectionprosthetic grafts

Identifiers

PMID25045278
PMCPMC4099194

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.